C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.
C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study.
Active, not recruiting · NCT03311451 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study. | Barrett esophagus, Digestive System Diseases, digestive system disorder, esophageal disorder, neoplasm, precancerous condition | Active, not recruiting | Not applicable | 2026-05-22 | NCT03311451 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merit Medical Systems, Inc. | 10 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AMC Medical Research B.V. | Amsterdam | Netherlands | 1 |
| Catharina Hospital Eindhoven | Eindhoven | Netherlands | 1 |
| Erasmus Medical Center | Rotterdam | Netherlands | 1 |
| St. Antonius Hospital | Nieuwegein | Netherlands | 14 |
| UMC Groningen | Groningen | Netherlands | 1 |
| UMC Utrecht | Utrecht | Netherlands | 1 |